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Abstract
It has been shown that DNA demethylation plays a pivotal role in the generation of induced pluripotent stem (iPS) cells.
However, the underlying mechanism of this action is still unclear. Previous reports indicated that activation-induced cytidine
deaminase (Aid, also known as Aicda) is involved in DNA demethylation in several developmental processes, as well as cell
fusion-mediated reprogramming. Based on these reports, we hypothesized that Aid may be involved in the DNA
demethylation that occurs during the generation of iPS cells. In this study, we examined the function of Aid in iPS cell
generation using Aid knockout (Aid2/2) mice expressing a GFP reporter under the control of a pluripotent stem cell marker,
Nanog. By introducing Oct3/4, Sox2, Klf4 and c-Myc, Nanog-GFP-positive iPS cells could be generated from the fibroblasts
and primary B cells of Aid2/2mice. Their induction efficiency was similar to that of wild-type (Aid+/+) iPS cells. The Aid2/2 iPS
cells showed normal proliferation and gave rise to chimeras, indicating their capacity for self-renewal and pluripotency. A
comprehensive DNA methylation analysis showed only a few differences between Aid+/+ and Aid2/2 iPS cells. These data
suggest that Aid does not have crucial functions in DNA demethylation during iPS cell generation.
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Introduction
Induced pluripotent stem (iPS) cells can be generated by
introducing defined factors into somatic cells [1]. iPS cells have the
capacity for self-renewal and pluripotency, similar to embryonic
stem (ES) cells [2,3]. It has been shown that the epigenetic status,
such as the presence of DNA methylation and histone modifica-
tions, changes dramatically during iPS cell generation [4–6]. For
instance, the promoter regions of HoxA10 and Gja8 were reported
to be methylated during the reprogramming process [7]. However,
de novo DNA methyltransferases, Dnmt3a and 3b, are dispensable
for the reprogramming of somatic cells to a pluripotent state [8].
On the other hand, the DNA methylation level of the Oct4 and
Nanog promoters dramatically decreases during iPS cell generation
[1]. Partially reprogrammed iPS cells showed hypermethylation in
these regions, suggesting that DNA demethylation is important for
the generation of fully reprogrammed cells [6]. However, the
mechanism(s) underlying the changes in methylation status are still
unclear.
There are considered to be two main possibilities for the
mechanism responsible for the DNA demethylation during iPS cell
generation. One is ‘passive DNA demethylation’ by the inhibition
of the maintenance DNA methyltransferase, Dnmt1, during DNA
replication [9]. The other possibility is ‘active DNA demethyla-
tion’ mediated by DNA demethylase or a demethylation complex,
which was reported to be composed of DNA deaminase and DNA
glycosylase [9,10].
Activation-induced cytidine deaminase (Aid, also known as
Aicda) converts methylated cytosine to thymine and unmethylated
cytosine to uracil by removing their amine residues [11]. Aid is
expressed in B cells upon antigen stimulation and generates point
mutations at their Ig locus, which is essential for the initiation of
class switch recombination and somatic hypermutation [12,13].
Recently, several reports suggested that Aid is involved in the
DNA demethylation that occurs during the developmental
processes in zebrafish and mice [10,14], while Aid2/2 mice
develop normally [12]. The DNA methylation level of the Oct4
and Nanog promoters in human fibroblasts were decreased during
the reprogramming process after fusion with mouse ES cells.
Interestingly, transient suppression of Aid expression has been
shown to inhibit this demethylation [15]. Aid is also involved in the
DNA demethylation that occurs in the adult mouse brain via the
5-hydroxymethylcytosine generated by Tet1 [16].
Based on these results, we hypothesized that Aid may play an
important role in DNA demethylation during iPS cell generation.
In this study, we employed a loss of function approach and
examined the effects of Aid depletion on the DNA methylation
status in mouse iPS cells. Aid depletion did not affect the efficiency
of iPS cell generation from the fibroblasts or primary B cells. The
characterization of Aid2/2 iPS cells showed that they were able to
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self-renew and had pluripotency. A comprehensive DNA meth-
ylation analysis showed few differences between Aid+/+ and Aid2/2
iPS cells. These results suggest that Aid does not have a crucial
function in the DNA demethylation that occurs during the
generation of iPS cells.
Results
Generation of iPS Cells from Aid2/2 Mice
We initially examined the expression of Aid in mouse embryonic
fibroblasts (MEFs), ES cells and iPS cells by quantitative RT-PCR.
The signal for Aid was detected in Aid+/+ MEFs, ES cells and Aid+/
+ iPS cells, although their levels were about 9900-, 3000- and 950-
fold lower than that of activated primary B cells, respectively
(Fig. 1A).
To examine the function of Aid in iPS cell generation, Aid2/2
mice expressing a Nanog-GFP reporter were generated by crossing
Aid2/2 mice [12] and Nanog-GFP mice [2], because Nanog is a
marker for iPS cell generation. Then, MEFs were isolated from the
mice, and iPS cells were induced by the introduction of Oct3/4,
Sox2 and Klf4 with or without c-Myc (4 Fs or 3 Fs, respectively)
using retrovirus vectors (Fig. S1A). GFP-positive colonies emerged
from the Aid2/2 MEFs under both conditions (Fig. 1B).
The resulting colonies were tightly packed and round-shaped,
and the cells had a high nuclear/cytoplasm ratio, which was
indistinguishable from that of the Aid+/+ iPS cells. The number of
GFP-positive colonies derived from Aid2/2 MEFs was 13.3613.9
from 103 input cells with 4 Fs and 2.662.3 from 104 input cells
with 3 Fs, which was comparable to that of Aid+/+ (17.8614.5 and
2.060.5) and Aid+/2 cells (10.264.4 and 3.761.5) (Figs. 1C and
D). Moreover, the overexpression of Aid did not affect the
induction efficiency, even though the expression level was
approximately 5,000 higher than that of Aid+/+ MEFs (Figs. 1C
and D and S2A). The number of total colonies (GFP-positive and
negative colonies) and the proportion of GFP-positive colonies in
Aid2/2 MEFs transduced with 3 Fs were comparable to those of
Aid+/+ MEFs (Figs. 1E and F).
Although no significant differences were observed in the
number of colonies, it is possible that there were differences in
the process of iPS cell generation. SSEA1 is a marker for the
progression of iPS cell generation [17,18]. We therefore examined
the number of SSEA1-positive cells at several time points after the
infection of the 4 Fs (Fig. S3). However, there were no significant
differences in the number of SSEA1-positive cells between the
Aid+/+ and Aid2/2 MEFs at any time point.
If Aid has only a limited effect on reprogramming, the high
expression of exogenous reprogramming factors might overwhelm
the lack of Aid. Therefore, we induced iPS cells with diluted
amounts (1 to 1/64) of retrovirus (Fig. S4). The number of GFP-
positive colonies generated from Aid2/2MEFs was 14.4612.0 (1),
9.465.8 (1/4), 4.863.6 (1/16) and 060 (1/64) and that of Aid+/+
iPS cells was 862.1 (1), 9.463.0 (1/4), 4.663.4 (1/16) and 060
(1/64), showing no statistically significant difference between
groups.
The expression level of Aid in MEFs was very low, so it was
considered to be plausible that the deletion of Aid would not affect
the efficiency of iPS cell generation. Thus, we introduced 4 Fs into
primary B cells, because their Aid expression was much higher
than that of MEFs. There were no significant differences between
Aid+/+ (23.2617.0) and Aid2/2 primary B cells (10.268.2) in terms
of the efficiency of iPS cell generation (Fig. 1G). The overexpres-
sion of Aid also did not affect the reprogramming efficiency
(Figs. 1G and S2B). Consequently, neither deletion nor overex-
pression of Aid affected the efficiency of iPS cell generation.
Although the depletion of Aid did not affect the induction
efficiency of iPS cells, it is possible that other genes might
compensate for the deletion. A recent paper showed that transient
knockdown of Aid decreased the efficiency of iPS cell generation
[19]. Hence, we tested several shRNA sequences using Aid+/+
MEFs, and found four-fold suppression of the expression by
shAid#3 (Fig. S5A). However, the addition of shAid#3 did not
affect the reprogramming efficiency (Figs. S5B and C). Apobec
family genes also have cytidine deamination activity, and were
reported to work as a component of the DNA demethylation
complex in zebrafish embryos [10]. To address their potential
compensatory effects, we introduced 4 Fs into Aid2/2 MEFs,
together with a dominant negative form of Apobec1, which lacks
deaminase activity [20]. Although the expression of the dominant
negative form was confirmed by quantitative RT-PCR (Fig. S6A),
it did not influence the efficiency of iPS cell generation (Fig. S6B).
In addition, the overexpression of Apobec1 itself also did not affect
the efficiency (Fig. S6B). These results suggest that Apobec1 did
not compensate for the deletion of Aid.
Characterization of Aid2/2 iPS Cells
To examine whether Aid deletion affected the quality of iPS
cells, we examined the morphology, proliferation, self-renewal
capacity, RNA expression and differentiation potential of Aid2/2
iPS cells in detail. Aid+/+ and Aid2/2 iPS colonies were generated
from Aid+/+ and Aid2/2 MEFs, and were selected from three
independent experiments. The clones were passaged four times on
feeder cells and two times on gelatin-coated dishes to exclude any
contamination of the feeder cells. Subsequently, the RNA and
genomic DNA were isolated. The proportions of iPS cell clones
showing undifferentiated characteristics throughout the culture
period were 90.7616.2% in Aid+/+ iPS cells and 91.7614.4% in
Aid2/2 iPS cells (Table S1). Clone independence was confirmed
by detecting the genomic integration pattern of retrovirally-
introduced Klf4 (Fig. S7). Mature iPS cell clones were selected by
the quantification of transgene suppression (Fig. S8), since it is a
marker of full reprogramming [2,6]. There was no statistically
significant differences between the Aid+/+ and Aid2/2 iPS cell
clones (Fig. S8). The lack of Aid was confirmed by genomic PCR
(Fig. S9). Finally, we selected nine Aid+/+ and Aid2/2 iPS cell
clones for further characterization (Fig. S8).
The Aid2/2 iPS cells were morphologically indistinguishable
from the Aid+/+ iPS cells (Fig. 2A). All of the Aid2/2 iPS cell clones
showed fluorescence of Nanog-GFP. Their doubling time was
16.360.7 h, which was comparable to that of Aid+/+ iPS cells
(16.460.7 h, Fig. 2B). When single Aid2/2 iPS cells were plated
into 96-well plates, 11.363.1 wells became positive for Nanog-
GFP colonies, similar to the number of Aid+/+ iPS cells (12610.4)
(Fig. S10A). The majority of Aid2/2 iPS cells in the colonies
expressed Nanog-GFP and the Oct3/4 protein (Fig. S10B). These
results indicated that Aid2/2 iPS cells had the capacity for self-
renewal, similar to that observed in Aid+/+ iPS cells.
Next, the expression levels of markers of pluripotent stem cells,
Nanog, endogenous Oct3/4, ERas, Esg1 and Ecat1, were quantified
by RT-PCR. Aid2/2 iPS cells exhibited 1.9-fold higher expression
of Ecat1 than in Aid+/+ iPS cells, while there were no statistically
significant differences in the other genes (Fig. 2C).
We then assessed the DNA methylation status of the Ecat1
promoter region. The proportion of methylated CpG was
89.060.7% in Aid+/+ MEFs (Fig. 2D). On the other hand, that
of Aid+/+ iPS cells and established, well-characterized iPS cells (E-
iPS cells), was 55.465.0% and 49.4%, respectively, which were
similar to that of ES cells (44.0633.0%) [2,21]. These results
indicated that the promoter region was demethylated during iPS
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cell generation. The DNA methylation level in Aid2/2 iPS cells
was 51.767.9%, which was comparable to that of the Aid+/+ iPS
cells, suggesting that the difference in Ecat1 expression was not due
to a change in the DNA methylation level in the Ecat1 promoter
region (Fig. 2D).
Subsequently, we compared the global gene expression profiles
of six Aid+/+ and six Aid2/2 iPS cell clones, and detected 12
downregulated and 26 upregulated probes among a total of 54,497
probes examined in Aid2/2 iPS clones (fold change .2, corrected
p-value ,0.05) (Fig. 2E and Table S2). A hierarchal cluster
analysis did not show any clear segregation of Aid+/+ and Aid2/2
iPS cells (Fig. S11). These results demonstrated that there were few
differences between Aid+/+ and Aid2/2 iPS cells in terms of the
global gene expression patterns.
To evaluate the differentiation potential of Aid2/2 iPS cells, we
first performed an in vitro differentiation assay. Aid+/+ and Aid2/2
iPS cells were differentiated through the formation of embryoid
bodies (EBs). Subsequently, the expression of marker genes for the
three germ layers was examined by immunostaining. Differenti-
ated Aid2/2 iPS cells expressed Sox17 (endoderm), smooth muscle
actin (SMA) (mesoderm) and bIII tubulin (ectoderm) (Figs. 2F and
S12). These results suggested that Aid2/2 iPS cells had the
capacity to differentiate into all three germ layers in vitro. We also
performed a teratoma formation assay and confirmed the potential
of the cells to differentiate into all three germ layers (data not
shown).
We then injected Aid2/2 iPS cells into early mouse embryos and
tested their contribution to adult chimeras (Fig. 2G). Chimeras
could be generated from seven out of eight clones of Aid2/2 iPS
cells (87.5%) (Table S3). The gonads were isolated from 13.5 days
post-coitum embryos to evaluate their differentiation into germline
cells. Nanog is a marker of primordial germ cells (PGC) [2,22],
and the existence of GFP-positive cells in the gonads indicated
their contribution to the germline (Fig. 2H). As a result, it was
concluded that Aid2/2 iPS cells have a capacity for self-renewal
and pluripotency that is similar to that of Aid+/+ iPS cells.
DNA Methylation Status of Aid2/2 iPS Cells
Since AID has been reported to play roles in the demethylation
of the human NANOG and OCT3/4 promoters in fusion-mediated
reprogramming [15], we analyzed the DNA methylation status of
mouse orthologous gene promoters in Aid2/2 iPS cells (Figs. 3A
and B). The methylation level of the Nanog promoter was high
(76.264.2%) in Aid+/+ MEFs, whereas it was low (11.162.6%) in
Aid+/+ iPS cells, as observed in previous reports (Fig. 3A) [1–3].
Aid2/2 iPS cells also showed 10.362.2% methylation, which was
not significantly different from that in Aid+/+ iPS cells. In the same
way, the Oct3/4 promoter showed hypomethylation in both Aid+/+
and Aid2/2 iPS cells (Fig. 3B).
We next assessed the DNA methylation level of the B1 repeat
and LINE1 sequences [23,24] to determine the effects of Aid
depletion on the global DNA methylation status (Figs. 3C and D).
The B1 and LINE1 sequences are distributed all over the genome,
and cover 2.6% and 19.2% of the mouse genome, respectively
[25]. Although there were variations among ES cells, the DNA
methylation level of the B1 repeat sequence in Aid+/+ MEFs
(72.360.3%) was higher than that of Aid+/+ iPS cells (54.163.2%),
thus suggesting a decrease in the methylation during iPS cell
generation (Fig. 3C). The B1 repeat regions in Aid2/2 iPS cells
showed a comparable level of DNA methylation (51.164.0%) to
that in Aid+/+ iPS cells. Similar results were obtained for the
LINE1 sequence, although the changes were smaller than those of
the B1 repeat (Fig. 3D).
To examine the global DNA methylation status of Aid2/2 iPS
cells in greater detail, we concentrated the methylated genomic
fragments by performing immunoprecipitation using the methyl-
CpG binding domain protein (MBD) and analyzed the methyl-
ation levels by deep sequencing (MBD-seq) [26]. The fragments
were mapped to the mouse genome (average, 79.467.6%, Table
S4) and subsequently, the peaks of the mapped tags were detected
by a MACS algorithm [27]. These peaks defined specific
methylated regions. Three or four cell lines were used for each
cell type. To evaluate the dispersion of the data on MBD-seq, we
first compared two cell samples for each cell type, and examined
the proportion of the overlap in methylated regions (Fig. S13A). In
the case of three Aid+/+ MEFs, the proportions were 69% (Aid+/+
MEF#1 vs Aid+/+ MEF#2), 62% (Aid+/+ MEF#1 vs Aid+/+
MEF#3) and 53% (Aid+/+ MEF#2 vs Aid+/+ MEF#3). On the
other hand, those of the Aid+/+ iPS cells, Aid2/2 iPS cells and ES
cells were 60 to 78% (n= 4), 63 to 77% (n= 4) and 27 to 46%
(n= 3), respectively. ES cells showed a relatively low overlap. This
was likely due to the differences in the original mouse strains
among these ES cell clones.
To confirm the validity of our studies, we carried out an
experiment to evaluate the reliability of the MBD-seq. From the
analysis of Aid+/+ iPS cells and parental Aid+/+ MEFs, a total of
43,458 methylated regions were detected (Figs. 3E and S13B,
Table S5). Among them, the numbers of differentially methylated
regions (DMRs) in Aid+/+ iPS cells and Aid+/+ MEFs were 17,371
(40%) and 1,934 (4.4%), respectively. In the case of Aid+/+ iPS cells
and ES cells, a total of 26,154 regions were detected (Figs. 3E and
S13C, Table S5). The numbers of DMRs in the Aid+/+ iPS cells
and ES cells were 1,172 (4.5%) and 30 (0.1%), respectively. The
proportion of DMRs between Aid+/+ iPS cells and Aid+/+ MEFs
(44.4%) was larger than that in Aid+/+ iPS cells and ES cells (4.6%),
thus suggesting that the analysis reflected the differences in the cell
types.
We next compared Aid+/+ iPS cells with Aid2/2 iPS cells, and
found a total of 52,014 regions (Figs. 3E and S13D, Tables S5 and
S6). Almost all regions were commonly methylated regions
(CMRs) (99.5%), and only 234 (0.4%) and 52 (0.1%) regions
were DMRs in Aid+/+ and Aid2/2 iPS cells, respectively.
Consequently, the MBD-seq exhibited few differences in the
global DNA methylation status between Aid+/+ and Aid2/2 iPS
cells.
Figure 1. Generation of iPS cells from Aid2/2 mice. (A) The relative expression of Aid and Gapdh. Total RNA was isolated from three ES cell
clones (RF8, B6ES and MG1.19), three Aid+/+ iPS cell clones (967B2, 967C1 and 979B1), three Aid2/2 iPS cell clones (957F1, 979F1 and 979E1), three
parental Aid+/+ and Aid2/2 MEF clones and primary B cells (pB cells), and was used for the quantitative RT-PCR analysis. The data are shown as the
average6 SD. (B) The morphology of Aid+/+ and Aid2/2 iPS colonies 25 days after the introduction of 4 Fs into MEFs. Phase contrast (left column) and
GFP fluorescence (right column) images are shown. Scale bars; 200 mm. (C, D) The number of GFP-positive colonies from Aid+/+, Aid+/2 and Aid2/2
MEFs induced by 4 Fs (C) and 3 Fs (D). For each genotype, three different lots of MEFs were used in each experiment, and the experiments were
repeated four times. Colonies were counted 25 (4 Fs) and 30 (3 Fs) days after the induction. (E) The number of total colonies from Aid+/+, Aid+/2 and
Aid2/2MEFs subjected to transduction of the 3 Fs with or without Aid. (F) The proportion of GFP-positive colonies out of the total colonies from Aid+/
+, Aid+/2 and Aid2/2 MEFs induced by 3 Fs with or without Aid. (G) The number of GFP-positive colonies from Aid+/+ and Aid2/2 primary B cells
induced with 4 Fs. Experiments were repeated five times.
doi:10.1371/journal.pone.0094735.g001
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Figure 2. Characterization of the Aid2/2 iPS cells. (A) The morphology of the Aid+/+ and Aid2/2 iPS cells cultured on gelatin-coated dishes
(passage 6). Phase contrast (left column) and GFP fluorescence (right column) images are shown. Scale bars; 200 mm. (B) The proliferation of the cells.
Three clones of ES cells, Aid+/+ iPS cells and Aid2/2 iPS cells were passaged every three days (36105 cells per well of a 6-well plate) on feeder-coated
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A pyrosequencing analysis revealed significant differences in the
DNA methylation levels at the Nanog and Ecat1 promoter regions
between Aid+/+ iPS cells and Aid+/+ MEFs (Figs. 2D and 3A).
However, the MBD-seq analysis of Aid+/+ MEF-DMRs compared
with Aid+/+ iPS cells did not include either of these promoters,
although there were some mapped reads detected at the Nanog
promoter in Aid+/+ MEFs (Fig. S13E). One possible explanation
for this different result is that MBD-seq is a method based on
immunoprecipitation, which can be affected by the density of
CpGs [28].
Discussion
Our findings demonstrated that Nanog-GFP-positive iPS cells
could be generated from Aid2/2 mice. The deletion, knockdown
and overexpression of Aid did not affect the efficiency of iPS cell
generation. Based on the results of our characterization, Aid2/2
iPS cells did not have any major defects in their capacity for self-
renewal or pluripotency. In addition, there were few significant
differences between Aid+/+ and Aid2/2 iPS cells in the compre-
hensive DNA methylation assay. These results suggest that Aid
does not have a crucial function in DNA demethylation during iPS
cell generation.
Previous studies have indicated that Aid is involved in DNA
demethylation in the early embryos of zebrafish, in mouse PGCs
and in the reprogramming of human fibroblasts fused with mouse
ES cells [10,14,15]. These studies led us to hypothesize that Aid
was also involved in the DNA demethylation that occurs during
iPS cell generation. However, our results did not support this
hypothesis. One possible reason was thought to be compensation
by other genes.
Bhutani et al. reported that transient knockdown of Aid in the
initial phase of iPS cell generation decreased the efficiency of
mouse iPS cell generation, while genomic deletion of Aid did not
affect it [19]. Based on these results, they suggested that there may
be compensation mechanisms for genomic depletion. We also
examined the effects of transient knockdown by the shRNA
sequences employed in their report. However, this transient
knockdown did not affect the efficiency of iPS cell generation in
our hands. Habib et al. reported similar results [29], thereby
supporting our present findings.
The effect of Aid overexpression is also controversial. Bhutani
et al. showed that the overexpression of human AID enhanced the
generation of mouse iPS cells [19]. On the contrary, the addition
of mouse Aid did not affect the reprogramming efficiency in our
current study. Kumar et al. and Habib et al. also examined the
effects of mouse Aid overexpression on the proportion of Oct3/4-
positive cells during iPS cell generation, and did not observe any
significant effect [29,30]. Further supporting our results, even in
mature B cells expressing abundant Aid (Fig. 1A), Aid was not
involved in determining the DNA methylation status [31,32]. The
homology of human and mouse Aid is 92% at the amino acid
sequence level. Although the homology is relatively high, it is still
possible that the differences might influence the effects of Aid
overexpression on the reprogramming.
After the formation of iPS colonies, the efficiency of establishing
stable cell lines from Aid2/2 MEFs (91.7614.4%) was comparable
to that from Aid+/+ MEFs (90.7616.2%, Table S1) in the present
study. On the other hand, Kumar et al. reported that five out of
12 Aid2/2 iPS cell colonies (41.7%), but zero out of 13 Aid+/+ iPS
cell colonies differentiated during the culture period [30], which
suggested the involvement of Aid in the maintenance of
pluripotency. This instability, however, could not be rescued by
the ectopic expression of Aid. They discussed that there may be
unknown molecular mechanism(s), beyond that mediated by Aid,
that contribute to the maintenance of pluripotency. It should be
noted that Aid2/2 ES cells can be established and give rise to
chimeric mice [12]. In addition, constitutive expression of Aid did
not disrupt general mouse development [33]. These reports
indicated that Aid may not have a crucial function in the
maintenance of pluripotency in ES cells.
There were several controversial studies about the function of
Aid in factor-mediated reprogramming, while all of these studies
showed the generation of iPS cell colonies from Aid2/2 mice. One
possible explanation for the diverse results is the differences in the
experimental settings among studies, such as the construction of
the reprogramming vectors, culture medium, the method used to
evaluate the reprogramming efficiency and the mouse strain. The
deaminase activity of Aid is reported to be regulated by its
phosphorylation at Thr27 and Ser38 [34,35], as well as its cellular
localization [36,37]. The experimental settings can also affect the
activity of Aid.
The expression of Ecat1 in Aid2/2 iPS cells was 1.9-fold higher
than that of Aid+/+ iPS cells (Fig. 2C). The function of Ecat1 in
pluripotent stem cells has not been well studied. Therefore, it is
difficult to speculate on the biological meaning of the difference in
expression. The methylation level of the promoter seemed to have
little effect on this distinct expression. The involvement of Aid in
the change in Ecat1 expression needs to be studied.
For the comprehensive DNA methylation assay, we employed
MBD-seq in combination with the detection of methylated regions
by using a MACS algorithm. It should be noted that this detection
is affected by the types of cells being examined. The number of
methylated regions in Aid+/+ iPS cells (94,615613,994) (Table S4)
was two times higher than that in Aid+/+ MEFs (47,278611,215).
These results were different from those in a previous report
showing that there were no significant differences between the
levels of global DNA methylation in ES cells and fibroblasts
examined by bisulfite sequencing [38]. We found a lot of small
peaks in the Aid+/+ MEFs compared with the Aid+/+ iPS cells in our
study (Fig. S13F). One possible cause of the small peaks is
populational heterogeneity. MEFs consist of variety of cell types,
while iPS cells are clonal uniform cells. It is possible that the small
peaks were recognized as background differences by the MACS
algorithm, and influenced its sensitivity of detection. On the other
hand, in the case of comparisons between the same cell type, such
dishes. (C) The relative expression of pluripotent stem cell marker genes. Total RNA was isolated from three ES cell clones, two E-iPS cell clones
(20D17 and 178B5), nine Aid+/+ iPS cell clones, nine Aid2/2 iPS cell clones and three clones each of parental Aid+/+ and Aid2/2 MEFs. The data were
normalized to the level of Gapdh. The average of the ES cell clones was set at a relative level of 1 (*, corrected p-value ,0.05). (D) The DNA
methylation level of the Ecat1 promoter detected by pyrosequencing. (E) Scatter plots showing a comparison of the global gene expression between
Aid+/+ and Aid2/2 iPS cells. The red dots indicate differentially expressed probes (corrected p-value,0.05). Green lines indicate two-fold changes. The
two most significant probes (arrowheads) were located at the 39 UTR of Aid and detected immature Aid mRNA in Aid2/2 iPS cells, which should be
driven by the inserted promoter in the drug resistance cassette. (F) The differentiation of Aid2/2 iPS cells in vitro. Differentiated Aid2/2 iPS cells were
stained with antibodies for Sox17, SMA and bIII tubulin. Bars; 100 mm. (G) A chimeric mouse established with Aid2/2 iPS cells. Black hair indicates the
contribution of the iPS cells. (H) Gonads isolated from 13.5 d.p.c chimeric embryos. GFP-positive cells (arrowheads) indicate the differentiation of
Aid2/2 iPS cells into PGCs. Bars; 200 mm.
doi:10.1371/journal.pone.0094735.g002
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as Aid+/+ iPS cells and Aid2/2 iPS cells, the number of detected
regions was 94,615613,994 and 85,968610,880, which was not
significantly different.
Our current study suggested that there is likely some yet to be
elucidated mechanism(s) responsible for demethylation during iPS
cell induction other than that involving Aid. The DNA methyl-
ation status is known to be related to the histone modifications
[39]. Recently, histone modifiers like Suv39H1, the NuRD
complex and Utx were reported to function during iPS cell
generation [40–42]. Therefore, if there are unknown DNA
demethylation enzyme(s), they may work with the interactions of
such histone modifiers. One possible candidate would be Tet2, an
enzyme converts 5-methylcytosine to 5-hydroxymethycytosine,
which is recently reported to function in DNA demethylation
Figure 3. The DNA methylation status of Aid2/2 iPS cells. (A–D) The DNA methylation status of the Nanog promoter (A), Oct3/4 promoter (B),
B1 (C) and LINE1 (D) detected by pyrosequencing. The iPS cell clones analyzed were the same as those examined in Fig. 2C. The data are represented
as the averages 6 SD of the clones. (E) The results of the comprehensive DNA methylation analysis with MBD-sequencing. Pie charts show the
comparison of the detected methylated regions between Aid+/+ iPS cells and Aid+/+ MEFs (left), Aid+/+ iPS cells and ES cells (middle), and Aid+/+ iPS
cells and Aid2/2 iPS cells (right). DMRs; Differentially methylated regions, CMRs; Commonly methylated regions.
doi:10.1371/journal.pone.0094735.g003
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during iPS cell generation [43]. It is also important to examine the
involvement of passive DNA demethylation, which dilutes
methylated DNA in a cell division-dependent manner. Treatment
of the reprogramming cells with inhibitors of DNA methylation
and histone modification, such as 5-azacytidine and trichostatin A,
would help to investigate these factors in greater detail.
As described above, Aid initiates class switch recombination and
somatic hypermutation by generating point mutations at Ig locus
in B cells [12,13]. In addition, Aid is also reported to generate
point mutations and/or double strand breaks at non-Ig locus, for
example BCL6, MYC, PIM1 and PAX5, which are related to the
cancer genesis [44–46]. These results suggest that Aid potentially
generate genomic mutation during iPS cell generation. Several
reports have indicated that iPS cell clones have genomic mutations
that occurred during the reprograming process and/or during cell
culture [47,48]. On the contrary, one paper showed that most of
the genomic mutations in iPS cells were preexisting in the parental
somatic cells [49]. Although it is still unclear whether iPS cells
develop genomic mutations during the reprogramming process,
the effect of Aid on mutations should be carefully examined.
In summary, we herein showed that mouse iPS cells can be
normally established in the absence of a functional Aid gene. The
Aid2/2 iPS cells were similar to the Aid+/+ iPS cells in terms of
their capacity for self-renewal and pluripotency, as well as their
DNA methylation status. These results suggest that Aid does not




The coding regions of mouse Aid (NM_009645.2, NCBI) and
mouse Apobec1 (NM_001134391, NCBI) were cloned from
mouse ES cells by RT-PCR. The PCR products were sequenced
and subcloned into pENTR-D-TOPO (Invitrogen) and recom-
bined with pMXs-gw [1] using LR recombinase according to
manufacturer’s instructions (Invitrogen). Mouse dominant-nega-
tive Apobec1 (H61K/C93S/C96S) [20] was generated by PCR-
based site-directed mutagenesis. To generate lentivirus vectors
encoding doxycycline-inducible reprogramming factors, TRE, the
Gateway cassette (Invitrogen) and rtTA2s-M2 (Clontech) were
introduced into a pLKO.1 backbone (#10878, Addgene). Then
coding sequences of Oct3/4, Sox2, Klf4 and c-Myc were inserted
by the LR reaction to make pLV-TRE-rtTA2s-M2-Oct3/4, -
Sox2, -Klf4 and -c-Myc. psPAX2 (#12260) and pMDG.2
(#12259) were obtained from Addgene. The primers used for
the construction of plasmids are listed in Table S7.
Mice
All mice used in this study were bred and sacrificed
appropriately following the code of ethics of the Animal Research
Committee of Kyoto University. The animal care and experi-
mental procedures used in this study were approved by the Animal
Research Committee of Kyoto University and were carried out
according to the Regulation on Animal Experimentation at Kyoto
University (approval ID: 2–10). To generate Aid2/2 Nanog-GFP
reporter mice, Aid2/2 mice (C57BL6) [12] were crossed with
Nanog-GFP mice [2].
Establishment of MEFs
The establishment of MEFs was performed from individual 13.5
d.p.c embryos, as described previously, with some modifications
[50]. Briefly, heads and gastrointestinal tract tissues were removed
from the embryos. The embryos were then dissected using a pair
of scissors and dissociated using trypsin. The cell suspensions were
plated onto a 100-mm gelatin-coated dish. Three days after the
plating, the MEFs were expanded to three 100-mm dishes. Three
days after the passage, the MEFs were trypsinized, divided into six
vials and frozen as a stock. Aid+/+ and Aid2/2 MEFs derived from
male mice, which were homozygous for the Nanog-GFP reporter,
were used for iPS cell generation. The littermates of Aid+/+ and
Aid2/2 mice were generated by crossing Aid heterozygous KO
male and female mice, and MEFs were also generated from these
mice.
Cell Culture
RF8 ES cells (129S4 background) [51], B6 ES cells (C57BL/6
background) [52] and MG1.19 (129/Ola background) [53] cells
were maintained in ES medium (DMEM containing 15% FBS,
2 mM L-glutamine, 16nonessential amino acids, 1.1 mM 2-
mercaptoetahanol, 50 units/mL penicillin and 50 mg/mL strep-
tomycin) with LIF on feeder cells, as described previously [2]. As a
source for LIF, we used the conditioned medium from Plat-E cells
[54] that had been transduced with a LIF-expressing vector. The
Aid+/+ and Aid2/2 iPS cells and E-iPS cells (20D17 and 178B5)
[2,21] were maintained in ES medium with LIF and 1.5 mg/mL
puromycin on feeder cells. MEFs were maintained in fibroblast
medium (DMEM containing 10% FCS, 50 units/mL penicillin
and 50 mg/mL streptomycin) as described previously [50]. The
Plat-E cells were maintained in fibroblast medium with 1 mg/mL
puromycin and 10 mg/mL blasticidin. Primary B cells were
maintained in RPMI 1640 supplemented with 10% FCS,
10 mM 2-mercaptoethanol, 5% NTCT, 20 mM HEPES, 2 mM
L-glutamine, 100 units/mL penicillin and 100 mg/mL streptomy-
cin, as described previously, with some modifications [55].
Generation and Establishment of Mouse iPS Cells from
MEFs Using Retroviruses
The generation of mouse iPS cells from MEFs was performed
using retroviruses as described previously, with some modifications
[50]. Briefly, Plat-E cells were seeded at 3.66106 cells per 100 mm
dish. On the following day, reprogramming factors were
independently introduced into Plat-E cells using the FuGENE 6
(Roche) transfection reagent. After 24 h, the medium was replaced
with fibroblast medium. MEFs were seeded in six-well plates at
26105 cells per well. The following day, virus-containing
supernatants from the Plat-E cultures were recovered and filtered
using a 0.45 mm pore size cellulose acetate filter. Equal volumes of
virus-containing supernatants were mixed together (for example,
viruses for Oct3/4, Sox2, Klf4, c-Myc and Aid), then the MEFs
were incubated in virus supernatant containing polybrene at a
final concentration of 4 mg/mL for 24 h. Four days after
transduction, the MEFs were reseeded onto dishes covered with
feeder cells. As the combinations of reprogramming factors affect
the efficiency of iPS cell generation [21,56], we re-seeded 103 cells
per 100 mm dish for 4 Fs and 104 cells for 3 Fs. One day after the
re-seeding, the medium was changed to ES cell medium with LIF.
The puromycin selection (1.5 mg/mL) was started from day 14 for
4 Fs and from day 21 for 3 Fs. The number of iPS colonies was
counted on day 25 for 4 Fs and on day 30 for 3 Fs.
To establish mouse iPS cells, GFP-positive iPS colonies were
mechanically picked up and passaged on feeder cells [50]. To
examine the number of SSEA1-positive cells, we reseeded 1.56103
MEFs onto gelatin-coated 6-well plates four days after the
transduction of 4 Fs and cultured them in ES medium. Eight,
12, 16, 20, 24 and 28 days after the transduction, we counted the
number of total cells and analyzed the proportion of SSEA1-
positive cells by flow cytometry The number of SSEA1-positive
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cells was calculated by multiplying the number of total cells by the
proportion of SSEA1-positive cells. The antibody used for flow
cytometry was an Alexa Fluor 647-conjugated anti-SSEA1
antibody (sc-21702 AF647, Santa Cruz Biotechnology).
Generation of Mouse iPS Cells from MEFs with
Lentiviruses
The 293T cells were seeded at 3.66106 cells per 100-mm dish.
On the following day, reprogramming factors were independently
introduced into 293T cells with psPAX2 and pMDG.2 using the
FuGENE 6 transfection reagent. After 24 h, the medium was
replaced with fibroblast medium containing 10 mM forskolin. Two
days after the removal of the transfection reagent, virus-containing
supernatants from the 293T cells were recovered and filtered with
a 0.45 mm pore size cellulose acetate filter. To enrich the
lentiviruses, PEG-it Virus Precipitation Solution (System Biosci-
ences) was added, and the mixture was kept at 4uC for 24 h
according to the manufacturer’s protocol. Finally, a two-fold
enriched lentivirus solution was prepared.
For iPS cell generation, equal volumes of lentiviruses which
encoded Oct3/4, Sox2, Klf4 and c-Myc were mixed together.
MEFs were seeded in six-well plates at 26105 cells per well one
day before the transduction. The following day, MEFs were
incubated in medium containing the viruses and polybrene at a
final concentration of 8 mg/mL for 24 h. One day after the
transduction, the virus supernatant was removed and changed to
ES medium containing doxycycline at a final concentration of
2 mg/mL. Four days after transduction, the MEFs were reseeded
onto dishes with feeder cells. The number of iPS colonies was
counted on day 30.
Isolation of Primary B Cells
Primary B cells were isolated from mouse spleens by
immunomagnetic depletion with anti-CD43 MicroBeads (Miltenyi
Biotech) [45]. The harvested cells were stimulated in the presence
of 25 mg/mL LPS (Roche) and 50 ng/mL IL-4 (Sigma-Aldrich)
for three days. After the stimulation, RNA was isolated for a
further analysis.
Generation of Mouse iPS Cells from Primary B Cells
CD43-negative primary B cells were isolated from mouse
spleens and stimulated in the presence of 25 mg/mL LPS (Roche)
and 50 ng/mL IL-4 (Sigma-Aldrich) for 24 h. Then, 106 cells were
cultured in 2 mL of the medium containing retroviruses encoding
reprogramming factors with LPS and IL-4 in one well of a six-well
plate for two days. After the infection, the medium was changed to
ES medium, and 56105 cells were reseeded onto SNL feeder cells
in the 100 mm dishes. On days five and seven, 10 mL of ES
medium was added to the dish, and the medium was replaced on
day nine. Twenty-five days after the B cell isolation, the number of
GFP-positive colonies was counted.
Gene Knockdown
The hairpin sequences for Aid and GFP were cloned into the
pLKO.1 vector. The preparation of lentiviruses was performed as
described above. One day before the transduction, MEFs were
seeded in 60-mm dishes at a concentration of 46105 cells/dish.
On the following day, MEFs were incubated in medium
containing the virus (es) and polybrene (8 mg/mL) for 24 h. Two
days after the infection, puromycin was added to the medium for
the selection of shRNA-expressing cells. Three days after the
addition of puromycin, the total RNA was isolated. The oligo
DNAs used for the hairpin sequences are listed in Table S7.
Southern Blot Analysis
Genomic DNA (6 mg) purified from cultured cells was digested
with BamHI and EcoRI, separated on 0.8% agarose gels and
transferred to nylon membranes (Amersham). The membranes
were incubated with digoxigenin (DIG)-labeled DNA probes in
DIG Easy Hyb Buffer (Roche) at 42uC with constant agitation.
After washing, an alkaline phosphatase-conjugated anti-DIG
antibody (1:10,000, Roche) was added to the membrane. Signals
were raised by CDP-star (Roche) and detected by the LAS3000
imaging system (FUJIFILM). The Klf4 cDNA probe was
generated using the DIG DNA labeling mix (Roche). The primers
used in this experiment are listed in Table S7.
RNA Isolation and Reverse Transcription
To exclude any contamination of the feeder cells, ES cells and
iPS cells were passaged twice on gelatin-coated dishes. Subse-
quently, the total RNA was isolated from the cells using the
TRIzol reagent (Invitrogen) according to the manufacturer’s
instructions. The extracted RNA was treated with TURBO
DNase (Ambion) for 30 minutes at 37uC to eliminate the genomic
DNA contamination. RNA (1 mg) was reverse transcribed with
RevaTra Ace (TOYOBO) using oligo-dT primers in a 20 mL
reaction volume. The cDNA was diluted with 80 mL distilled
water, and 2 mL of the dilution was used for PCR assays.
Quantitative PCR
Quantitative PCR was performed with the StepOnePlus Real-
Time PCR system (Applied Bio Systems) and SYBR premix Ex
TaqII (Takara) according to the manufacturer’s instructions. The
primers used for the PCR reaction are listed in Table S7.
Western Blot Analysis
The Western blot analyses were performed as described
previously, with some modifications [57]. Briefly, 56105 primary
B cells were lysed with 50 mL 16NuPAGE LDS Sample Buffer
(Life Technologies) according to manufacturer’s protocol. Subse-
quently, we used 7 mL of the sample for electrophoresis on 12%
SDS-polyacrylamide gel, and transferred the proteins to a
polyvinylidine difluoride membrane (Millipore). The blot was
blocked with TBST (20 mM Tris-HCl, pH 7.6, 136 mM NaCl,
and 0.1% Tween-20) containing 5% skim milk. The membranes
were incubated in Can Get Signal Immunoreaction Enhancer
Solution I (TOYOBO) with primary antibody solution at 4uC
overnight. Then, the membrane was incubated in Can Get Signal
Immunoreaction Enhancer Solution II (TOYOBO) with a
horseradish peroxidase (HRP)-conjugated secondary antibody for
1 hr at room temperature. Signals were detected with the ECL
Prime Western Blotting Detection System (GE Healthcare) and
the LAS3000 imaging system (FUJIFILM, Japan). The antibodies
used for the Western blotting analysis were anti-Aid (1:1000,
mAID-2, eBioscience), anti-b actin (1:1000, AC15, Sigma-
Aldrich), anti-mouse IgG-HRP (1:1000, #7076, Cell Signaling)
and anti-rat IgG-HRP (1:1000, #712-035-153, Jackson Immu-
noResearch).
Clonogenic Assay
Nanog-GFP-positive and DAPI-staining-negative single iPS
cells were plated into each well of 96-well plates after being
sorted by a FACS Aria instrument (BD). Seven days after plating,
the cells were fixed and stained with an anti-Oct3/4 antibody
(1:100, C-10, Santa Cruz Biotechnology) and DAPI (Sigma-
Aldrich). The secondary antibody used was Alexa Fluor 647-
conjugated goat anti-mouse IgG (1:500, Life Technologies).
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Subsequently, the number of Nanog-GFP positive colonies was
counted.
In vitro Differentiation
For the EB formation, iPS cells were harvested by trypsinization
and transferred to bacterial culture dishes in ES medium without
LIF. After seven days, the EBs were photographed and plated into
gelatin-coated dishes for another three days. The cells were fixed
with PBS containing 4% paraformaldehyde for 15 minutes at
room temperature. Immunostaining was performed as described
previously [57]. The primary antibodies used were an anti-Sox17
antibody (1:200, R&D Systems), anti-SMA antibody (1:500, 1A4,
DAKO) and anti-bIII tubulin (1:1000, TUJ1, Covance). The
secondary antibodies used were Alexa Fluor 488-conjugated
donkey anti-Goat IgG (1:500, Life Technologies) for Sox17, and
Alexa Fluor 546-conjugated donkey anti-mouse IgG (1:500, Life
Technologies) for SMA and bIII tubulin.
Chimera Formation
Ten to fifteen iPS cells were injected into MCH (ICR)-derived
blastocysts. After the injection, the blastocysts were transplanted
into the uteri of pseudo-pregnant mice.
DNA Microarray
Total RNA was labeled with Cy3 and hybridized to the Whole
Mouse Genome Microarray (Agilent, catalog no. 28005) as
described previously, with some modifications [2]. The data were
analyzed with the GeneSpring GX version 11 software program
(Agilent). Quantile normalization (75%) was performed. The
microarray data are available from the Gene Expression Omnibus
(GEO), and appear under the accession number GSE51955.
Pyrosequencing
Bisulfite treatment was performed using the EZ DNA methyl-
ation-Gold Kit (ZYMO RESEARCH) with 2 mg of input genomic
DNA. The treated DNA was eluted with 20 mL elution buffer, and
the concentration was adjusted to 5 ng/mL with distilled water.
Subsequently, we performed PCR using 1 mL of the bisulfite-
converted genome. PCR products were sequenced using the
PyroMark Q96 ID (Qiagen) according to the manufacturer’s
protocol. To assess the DNA methylation status of the B1 repeat
and LINE1 sequences, the ADS010/Mouse B1 Element Methyl-
ation Analysis (EpigenDX) and ADS685/Mouse Line-1 Global
Methylation Assay (EpigenDX) were used. The primers used in
this experiment are listed in Table S7.
MBD-sequencing
Genomic DNA was sonicated to 100–300 bp fragments with a
Covaris E210 (Covaris) device. Methylated DNA was enriched
with an EpiXplore Methylated DNA Enrichment Kit (Takara)
according to the manufacturer’s protocol. The enriched methyl-
ated DNA was sequenced with a Hiseq2000 device (Illumina). The
data were mapped to the mouse genome (UCSC assembly mm9,
NCBI built 37) using the BWA 0.5.9rc1 software program (http://
bioinformatics.oxfordjournals.org/content/25/14/1754). Peaks
were detected by the MACS version 1.4.1 software program
(http://genomebiology.com/2008/9/9/r137), with a default p-
value threshold of p,1025 [58]. For the comparison of two cell
types, we extracted the overlapping methylated regions among one
cell type and examined whether the overlapping regions were also
detected in each of the samples of the other cell type, one by one.
Subsequently, the regions detected in all samples of one cell type
but not in any samples of another cell type were defined as
differentially methylated regions (DMRs). When the regions were
detected in all samples of both cell types, we named them
commonly methylated regions (CMRs). The extraction of
overlapping methylated regions was done by a modified method
based on intersectBed, which is a component of the BEDTools
software program [59]. The annotation of the methylated regions
was performed according to the RefSeq database. The data are
available from the Gene Expression Omnibus (GEO), under the
accession number GSE52136.
Statistical Analyses
The data are shown as the averages and standard deviations of
clones or experiments. Student’s t-test was used for the statistical
analysis. For multiple testing correction for the microarray analysis
and RT-PCR analysis of pluripotent stem cell marker genes, the
Benjamini & Hochberg correction was used.
Supporting Information
Figure S1 A schematic diagram showing the schedule of mouse
iPS cell induction from MEFs and primary B cells. (A) A schematic
diagram of the schedule of mouse iPS cell induction from MEFs.
MEFs, mouse embryonic fibroblasts; DMEM, Dulbecco’s modi-
fied Eagle medium; FBS, fetal bovine serum; LIF, leukemia
inhibitory factor. (B) A schematic diagram of the schedule of
mouse iPS cell induction from primary B cells. LPS, lipopolysac-
charide; IL-4, Interleukin-4.
(PDF)
Figure S2 Confirmation of Aid overexpression. (A) Total RNA
was isolated from MEFs which were induced by 4 Fs, together
with Aid. The data were normalized to the level of Gapdh and the
control was set at a relative level of 1. The data are the averages 6
SD of three independent experiments. (B) The results of a Western
blot analysis of Aid in Aid+/+ and Aid2/2 primary B cells induced
by 4 Fs together with Aid.
(PDF)
Figure S3 The number of SSEA1-positive cells generated during
iPS cell generation. Aid+/+ and Aid2/2MEFs were transfected with
4 Fs on day zero and re-seeded onto gelatin-coated 6-well plates
on day four (1.56103 cells). Subsequently, the number of SSEA1-
positive cells was examined by flow cytometry on day 8, 12, 16, 20,
24 and 28. The data are the averages 6 SD of three independent
experiments.
(PDF)
Figure S4 The efficiency of iPS cell generation from Aid2/2
MEFs with various expression levels of reprogramming factors.
Aid+/+ and Aid2/2 MEFs were infected with various amounts (1 to
1/64) of retrovirus 4 Fs, and the number of Nanog-GFP-positive
colonies was counted 25 days after the infection. The data are the
averages 6 SD of five independent experiments.
(PDF)
Figure S5 Effects of Aid knockdown on the efficiency of iPS cell
generation. (A) The knockdown efficiency of shAids. Lentiviruses
encoding shRNA sequences for Aid were infected into MEFs.
From days two to five after the infection, puromycin selection was
performed for shRNA expression. The total RNA was extracted
five days after the infection. The expression of Aid was examined
by quantitative RT-PCR. The data were normalized to Gapdh, and
the level in cells transfected with the scrambled shRNA was set at a
relative level of 1. The data are the averages 6 SD of three
independent experiments. *, P,0.05. (B) The schedule of Aid
knockdown during iPS cell generation. On day 0, a mixture of
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lentiviruses containing doxycycline (dox)-inducible Oct3/4, Sox2,
Kfl4 and c-Myc, and constitutive shRNA, were transfected into
MEFs. On day 1, dox was added to the culture medium to induce
the expression of reprogramming factors. The shRNA-expressing
cells were selected by puromycin treatment from days 2 to 4. The
MEFs were then re-seeded onto SNL feeder cells on day 4. The
number of GFP-positive colonies was counted 30 days after the
infection. (C) The effects of Aid knockdown on the efficiency of iPS
cell generation. 4 Fs were transfected into Aid+/+ and Aid2/2
MEFs along with shRNAs. The number of GFP-positive colonies
was counted 30 days after the infection. The data are shown as the
averages 6 SD of three independent experiments.
(PDF)
Figure S6 Effects of Apobec1 and its dominant negative form on
the efficiency of iPS cell generation. (A) The expression of
Apobec1 (Apo1) and the dominant negative form of Apobec1
(Apo1DN) in MEFs was examined by quantitative RT-PCR. The
data were normalized to Gapdh, and the control (Cont) was set at a
relative level of 1. The data are the averages 6 SD of the three
independent experiments. (B) The number of GFP-positive
colonies from Aid+/+, Aid+/2 and Aid2/2 MEFs induced by 4 Fs,
and transfected with Apo1 or Apo1DN, 25 days after the
induction.
(PDF)
Figure S7 The results of a Southern blot analysis of the
transgene integration with a Klf4 cDNA probe. The arrowhead
indicates the endogenous Klf4 allele. Aid+/+ iPS cell clones, 967B2
and 967B3 and 967C2 and 967C3; and Aid2/2 iPS cell clones,
979F4 and 979F5, 981E1 and 981E2 and 981E4 and 981E7, were
apparently the same clones based on their integration patterns
(asterisk).
(PDF)
Figure S8 The relative expression levels of transgenes. Total
RNA was isolated from Fbx15 reporter iPS cells (Fbx-iPS) [1],
established iPS cells (20D17 and 178B5), Aid+/+ iPS cell clones and
Aid2/2 iPS cell clones, and was used for a quantitative RT-PCR
analysis. Each experiment was repeated two times, and the
averages are shown. The data were normalized to Gapdh, and the
data for Fbx-iPS cells was set at a relative level of 1. The third and
fourth bars from the left side show the averages of the Aid+/+ and
Aid2/2 iPS clones, respectively. The error bars represent the SD of
the clones. The arrowhead indicates the clones selected for
characterization.
(PDF)
Figure S9 The results of a genotyping analysis of the Aid+/+ and
Aid2/2 iPS cell clones. Genomic DNA was isolated from Aid+/+
iPS cell clones and Aid2/2 iPS cell clones. The genotyping analysis
was performed by PCR. The primers used for this experiment are
listed in Table S7.
(PDF)
Figure S10 Clonogenic assay. (A) The number of Nanog-GFP
positive colonies in 96-well plates. Single Aid+/+ and Aid2/2 iPS
cells were plated into 96-well plates, and the number of Nanog-
GFP-positive colonies was counted after seven days. The data are
the averages 6 SD of three iPS cell clones. (B) The expression of
the Oct4 and Nanog-GFP proteins. Aid+/+ and Aid2/2 iPS cell
colonies were stained with an antibody for Oct3/4, along with 4’,
6-Diamidino-2-Phenylindole (DAPI). Bars; 100 mm.
(PDF)
Figure S11 Hierarchical clustering. The hierarchical clustering
analysis of gene expression was performed using all detected
probes.
(PDF)
Figure S12 In vitro differentiation of Aid2/2 iPS cells. Aid+/+
(967C1 and 979B1) and Aid2/2 iPS cell clones (979F1 and 981E1)
were differentiated in vitro through the formation of EBs, and were
stained with antibodies for Sox17, SMA and bIII tubulin. Bars;
100 mm.
(PDF)
Figure S13 MBD-sequencing. (A) The proportion of overlap-
ping methylated regions between biological replicates. The
proportion was calculated by dividing the number of overlapping
regions by the number of total regions detected in the two samples.
(B–D) Representative methylated regions identified by the
comparison of Aid+/+ MEFs and Aid+/+ iPS cells (B), ES cells
and Aid+/+ iPS cells (C) and Aid+/+ and Aid2/2 iPS cells (D). RPM;
Reads per million mapped reads. (E) The number of mapped
reads at the Nanog and Ecat1 promoter regions in Aid+/+ MEFs
and Aid+/+ iPS cells. Asterisks indicate the regions examined by
pryosequencing in Figs. 2D (Nanog promoter) and 3A (Ecat1
promoter). (F) Representative small peaks in Aid+/+ MEFs.
(PDF)
Table S1 The efficiency of establishing Aid2/2 iPS cells.
(PDF)
Table S2 A list of the differentially expressed probes between
Aid+/+ and Aid2/2 iPS cells.
(PDF)
Table S3 A summary of the blastocyst injections.
(PDF)
Table S4 A summary of the MBD-seq findings.
(PDF)
Table S5 The classification of the methylated regions detected
by MBD-seq.
(PDF)
Table S6 A list of the methylated regions detected by MBD-seq
(Aid+/+ iPS cells vs. Aid2/2 iPS cells).
(XLS)
Table S7 The primers used in the present study.
(PDF)
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Photos labeled 967B2, 957F1 and 979F1 in the previous figure 1B (left) were incorrect. Their exact clone 
names and genotypes are shown in red. We mixed up images of iPS cell clones having same genotype by 
mistake. Right panels are collected figure, in which iPS cell colonies derived from wild-type and Aid-deficient 
cells express GFP protein indicating successful reprogramming. Both previous and collected figures showed 
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